gabexate has been researched along with Blood Pressure, Low in 1 studies
Gabexate: A serine proteinase inhibitor used therapeutically in the treatment of pancreatitis, disseminated intravascular coagulation (DIC), and as a regional anticoagulant for hemodialysis. The drug inhibits the hydrolytic effects of thrombin, plasmin, and kallikrein, but not of chymotrypsin and aprotinin.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Miyawaki, T | 1 |
| Sameshima, T | 1 |
| Miyao, J | 1 |
| Oda, T | 1 |
1 other study available for gabexate and Blood Pressure, Low
| Article | Year |
|---|---|
[Effects of FOY on lysosomes in hemorrhagic hypotension--a histological analysis].
Topics: Animals; Gabexate; Guanidines; Hypotension; Liver; Lysosomes; Male; Protease Inhibitors; Rats; Rats, | 1984 |